Big Idea
LiMM Therapeutics is a biopharmaceutical company harnessing the molecular crosstalk between neuronal and innate lymphoid cells (ILCs) within peripheral tissues. By decoding the language of the neuro-immune crosstalk, we are developing first-in-class therapeutic products – NRILs: neuronal reprogrammers of innate lymphocytes – to preserve health and treat inflammatory and metabolic diseases and cancer. We are bridging neural sensing and immunology discoveries to unlock therapeutic solutions for the benefit of patients.
Team
David Braga Malta – Founder; Henrique Veiga-Fernandes – Founder
Portugal Ventures’ Investment Manager
